JP2005509007A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005509007A5 JP2005509007A5 JP2003543609A JP2003543609A JP2005509007A5 JP 2005509007 A5 JP2005509007 A5 JP 2005509007A5 JP 2003543609 A JP2003543609 A JP 2003543609A JP 2003543609 A JP2003543609 A JP 2003543609A JP 2005509007 A5 JP2005509007 A5 JP 2005509007A5
- Authority
- JP
- Japan
- Prior art keywords
- sulfo
- sulfoamino
- deoxy
- pharmaceutical composition
- glucopyranosyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000004476 Acute Coronary Syndrome Diseases 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01204323 | 2001-11-13 | ||
| EP01204323.8 | 2001-11-13 | ||
| PCT/EP2002/012482 WO2003041722A1 (en) | 2001-11-13 | 2002-11-07 | Use of specific dose of fondaparinux sodium for the treatment of acs |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2005509007A JP2005509007A (ja) | 2005-04-07 |
| JP2005509007A6 JP2005509007A6 (ja) | 2005-08-04 |
| JP2005509007A5 true JP2005509007A5 (enExample) | 2006-01-05 |
| JP4523276B2 JP4523276B2 (ja) | 2010-08-11 |
Family
ID=8181220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003543609A Expired - Fee Related JP4523276B2 (ja) | 2001-11-13 | 2002-11-07 | Ａｃｓの治療のためのフォンダパリヌックスナトリウムの特定投与量の使用 |
Country Status (36)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090075910A1 (en) * | 2007-09-13 | 2009-03-19 | Protia, Llc | Deuterium-enriched fondaparinux |
| CN107531798B (zh) * | 2015-03-20 | 2022-02-18 | 奥胡斯大学 | Pcsk9的抑制剂用于脂蛋白代谢病症的治疗 |
| US10688249B2 (en) * | 2015-06-11 | 2020-06-23 | Virchow Biotech Pvt. Ltd. | Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same |
| CN107595769A (zh) * | 2017-10-23 | 2018-01-19 | 上海博悦生物科技有限公司 | 一种磺达肝癸钠注射液组合物的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2662442A1 (fr) * | 1990-05-23 | 1991-11-29 | Midy Spa | Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant. |
| CA2199642C (en) * | 1997-03-10 | 2001-05-08 | Roger Cariou | Compositions containing an association of aspirin and an anti-xa oligosaccharide and use of an anti-xa oligosaccharide optionally in combination with aspirin |
| FR2764511B1 (fr) * | 1997-06-13 | 2000-09-08 | Sanofi Sa | Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire |
| JP2006501815A (ja) * | 2002-04-25 | 2006-01-19 | モメンタ ファーマシューティカルズ インコーポレイテッド | 粘膜送達のための方法および製品 |
-
2002
- 2002-07-11 UA UA2004032373A patent/UA80399C2/uk unknown
- 2002-11-07 BR BR0212915-9A patent/BR0212915A/pt not_active Application Discontinuation
- 2002-11-07 EA EA200400382A patent/EA007325B1/ru unknown
- 2002-11-07 CA CA002465776A patent/CA2465776A1/en not_active Abandoned
- 2002-11-07 NZ NZ552129A patent/NZ552129A/en not_active IP Right Cessation
- 2002-11-07 DK DK02787601T patent/DK1446131T3/da active
- 2002-11-07 AP APAP/P/2004/003014A patent/AP1820A/en active
- 2002-11-07 WO PCT/EP2002/012482 patent/WO2003041722A1/en not_active Ceased
- 2002-11-07 IL IL16111402A patent/IL161114A0/xx unknown
- 2002-11-07 US US10/492,102 patent/US20040248848A1/en not_active Abandoned
- 2002-11-07 ES ES02787601T patent/ES2287343T3/es not_active Expired - Lifetime
- 2002-11-07 AU AU2002351915A patent/AU2002351915B2/en not_active Expired
- 2002-11-07 PL PL369027A patent/PL206008B1/pl unknown
- 2002-11-07 AT AT02787601T patent/ATE361753T1/de active
- 2002-11-07 EP EP02787601A patent/EP1446131B1/en not_active Expired - Lifetime
- 2002-11-07 JP JP2003543609A patent/JP4523276B2/ja not_active Expired - Fee Related
- 2002-11-07 HU HU0401462A patent/HU228959B1/hu unknown
- 2002-11-07 ME MEP-11/08A patent/MEP1108A/xx unknown
- 2002-11-07 SI SI200230578T patent/SI1446131T1/sl unknown
- 2002-11-07 PT PT02787601T patent/PT1446131E/pt unknown
- 2002-11-07 ME MEP-2008-11A patent/ME00229B/me unknown
- 2002-11-07 DE DE60220084T patent/DE60220084T2/de not_active Expired - Lifetime
- 2002-11-07 MX MXPA04003045A patent/MXPA04003045A/es active IP Right Grant
- 2002-11-07 PE PE2002001086A patent/PE20030740A1/es not_active Application Discontinuation
- 2002-11-07 KR KR1020047004779A patent/KR20050044318A/ko not_active Ceased
- 2002-11-07 HR HR20040303A patent/HRP20040303B1/xx not_active IP Right Cessation
- 2002-11-07 GE GE5516A patent/GEP20074097B/en unknown
- 2002-11-07 CN CNA028192567A patent/CN1602197A/zh active Pending
- 2002-11-07 RS YUP-267/04A patent/RS50906B/sr unknown
- 2002-11-11 AR ARP020104308A patent/AR037291A1/es unknown
-
2004
- 2004-03-25 IL IL161114A patent/IL161114A/en active IP Right Grant
- 2004-03-29 ZA ZA2004/02464A patent/ZA200402464B/en unknown
- 2004-03-29 IS IS7199A patent/IS2484B/is unknown
- 2004-03-30 NO NO20041320A patent/NO20041320L/no not_active Application Discontinuation
- 2004-03-31 MA MA27602A patent/MA27071A1/fr unknown
- 2004-03-31 EC EC2004005041A patent/ECSP045041A/es unknown
- 2004-03-31 CO CO04030711A patent/CO5580790A2/es not_active Application Discontinuation
-
2007
- 2007-07-30 CY CY20071101000T patent/CY1106765T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3782612T3 (fi) | Sytidiinianalogien oraalisia formulaatioita ja menetelmiä niiden käyttämiseksi | |
| JP2005515966A5 (enExample) | ||
| JPH11139971A5 (enExample) | ||
| CO5280073A1 (es) | Composiciones | |
| AR037490A1 (es) | Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos | |
| CA2323680A1 (en) | Orally disintegrable tablets | |
| RU2005115855A (ru) | Композиция трамадола продлонгированного высвобождением с 24-часовым действием | |
| UY24875A1 (es) | Composiciones farmacéuticas conteniendo tetrahidrolipstatina | |
| NO20030897L (no) | Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer | |
| JP2005508955A5 (enExample) | ||
| CA2429639A1 (en) | Stable azithromycin monohydrate | |
| DK1225902T3 (da) | Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden | |
| ES2142430T3 (es) | Compuestos farmaceuticos en forma de gel conteniendo sales de sulfato de condroitina apropiadas para administracion oral. | |
| RU2000119750A (ru) | Новые пентасахариды, способы их получения и содержащие их фармацевтические композиции | |
| WO2004021985A3 (en) | Verifiable absorption drug delivery form based on cyclodextrins | |
| JP2004522780A5 (enExample) | ||
| HUP9902559A2 (hu) | Paracetamolt és drotavenint tartalmazó gyógyszerkészítmény és eljárás előállítására | |
| CY1106765T1 (el) | Χρηση ειδικης δοσης του νατριουχου φονταπαρινιδιου για τη θεραπεια των acs | |
| YU81101A (sh) | Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija | |
| NO965468L (no) | Farmasöytisk preparat for forhindring og/eller behandling av virale infeksjoner og eventuelle inflammasjoner, så vel som en behandlingsmetode derfor | |
| JPH09118624A5 (enExample) | ||
| RU2000115604A (ru) | Композиционный состав антибактериального лекарственного средства | |
| JP2005519919A5 (enExample) | ||
| SE0103613D0 (sv) | Novel formulation | |
| BRPI0506710A (pt) | composições farmacêuticas de liberação controlada |